These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 26157794)

  • 21. Lysosomal protein turnover contributes to the acquisition of TGFβ-1 induced invasive properties of mammary cancer cells.
    Kern U; Wischnewski V; Biniossek ML; Schilling O; Reinheckel T
    Mol Cancer; 2015 Feb; 14():39. PubMed ID: 25744631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Lysosomal cysteine proteinases at neoplastic transformation].
    Dilakian EA; Tsvetkova IV
    Biomed Khim; 2005; 51(5):485-500. PubMed ID: 16342665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cathepsin family and their role in colorectal cancer.
    Kuester D; Lippert H; Roessner A; Krueger S
    Pathol Res Pract; 2008; 204(7):491-500. PubMed ID: 18573619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lysosomal cysteine proteases: more than scavengers.
    Turk B; Turk D; Turk V
    Biochim Biophys Acta; 2000 Mar; 1477(1-2):98-111. PubMed ID: 10708852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Importance of lysosomal cysteine proteases in lung disease.
    Wolters PJ; Chapman HA
    Respir Res; 2000; 1(3):170-7. PubMed ID: 11667982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cysteine cathepsins: cellular roadmap to different functions.
    Brix K; Dunkhorst A; Mayer K; Jordans S
    Biochimie; 2008 Feb; 90(2):194-207. PubMed ID: 17825974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cysteine cathepsins in extracellular matrix remodeling: Extracellular matrix degradation and beyond.
    Vizovišek M; Fonović M; Turk B
    Matrix Biol; 2019 Jan; 75-76():141-159. PubMed ID: 29409929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Papain-like cysteine proteases.
    Brömme D
    Curr Protoc Protein Sci; 2001 May; Chapter 21():Unit 21.2. PubMed ID: 18429163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cysteine cathepsin activity suppresses osteoclastogenesis of myeloid-derived suppressor cells in breast cancer.
    Edgington-Mitchell LE; Rautela J; Duivenvoorden HM; Jayatilleke KM; van der Linden WA; Verdoes M; Bogyo M; Parker BS
    Oncotarget; 2015 Sep; 6(29):27008-22. PubMed ID: 26308073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence that serpin architecture intrinsically supports papain-like cysteine protease inhibition: engineering alpha(1)-antitrypsin to inhibit cathepsin proteases.
    Irving JA; Pike RN; Dai W; Brömme D; Worrall DM; Silverman GA; Coetzer TH; Dennison C; Bottomley SP; Whisstock JC
    Biochemistry; 2002 Apr; 41(15):4998-5004. PubMed ID: 11939796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response.
    Olson OC; Joyce JA
    Nat Rev Cancer; 2015 Dec; 15(12):712-29. PubMed ID: 26597527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual-Modality Activity-Based Probes as Molecular Imaging Agents for Vascular Inflammation.
    Withana NP; Saito T; Ma X; Garland M; Liu C; Kosuge H; Amsallem M; Verdoes M; Ofori LO; Fischbein M; Arakawa M; Cheng Z; McConnell MV; Bogyo M
    J Nucl Med; 2016 Oct; 57(10):1583-1590. PubMed ID: 27199363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cathepsins in digestive cancers.
    Chen S; Dong H; Yang S; Guo H
    Oncotarget; 2017 Jun; 8(25):41690-41700. PubMed ID: 28402938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Multifaceted Role of the Lysosomal Protease Cathepsins in Kidney Disease.
    Cocchiaro P; De Pasquale V; Della Morte R; Tafuri S; Avallone L; Pizard A; Moles A; Pavone LM
    Front Cell Dev Biol; 2017; 5():114. PubMed ID: 29312937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel broad-spectrum activity-based probes to profile malarial cysteine proteases.
    Tan MSY; Davison D; Sanchez MI; Anderson BM; Howell S; Snijders A; Edgington-Mitchell LE; Deu E
    PLoS One; 2020; 15(1):e0227341. PubMed ID: 31923258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prodrug-inspired probes selective to cathepsin B over other cysteine cathepsins.
    Chowdhury MA; Moya IA; Bhilocha S; McMillan CC; Vigliarolo BG; Zehbe I; Phenix CP
    J Med Chem; 2014 Jul; 57(14):6092-104. PubMed ID: 24940640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo imaging of intraperitoneally disseminated tumors in model mice by using activatable fluorescent small-molecular probes for activity of cathepsins.
    Fujii T; Kamiya M; Urano Y
    Bioconjug Chem; 2014 Oct; 25(10):1838-46. PubMed ID: 25196809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strategies for detection and quantification of cysteine cathepsins-evolution from bench to bedside.
    Hughes CS; Burden RE; Gilmore BF; Scott CJ
    Biochimie; 2016 Mar; 122():48-61. PubMed ID: 26253694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lysosomal cysteine proteases: structure, function and inhibition of cathepsins.
    Roberts R
    Drug News Perspect; 2005 Dec; 18(10):605-14. PubMed ID: 16491162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Future of Cysteine Cathepsins in Disease Management.
    Kramer L; Turk D; Turk B
    Trends Pharmacol Sci; 2017 Oct; 38(10):873-898. PubMed ID: 28668224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.